BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06644443 · RECRUITING
Trial details
- NCT number
- NCT06644443
- Sponsor
- Shenzhen University General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-15
- Primary completion
- 2025-07-14
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.